skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Attendees of the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting in Chicago were recently privy to five days of presentations, updates and the newest available data in the field. We invite you to take a look at some of the most important findings from the meeting, along with expert analysis of the results in this free sample of Biomedtracker’s 2016 Post-ASCO Report.

In this report, discover the key findings from “Collective Wisdom: The Future of Patient Centered Care and Research”, the theme of this year’s gathering. Highlights of the full report include:


  • New immune therapies currently in development, including CAR-T immunotherapies
  • Evaluations of combination treatments
  • Advancements in mutational subgroups for breast and lung cancers
  • Biomarker news, including the push to develop PD-1 biomarkers


This free sample of the 2016 Post-ASCO Report is brought to you by Biomedtracker and Meddevicetracker. Powered by real-time intelligence, Biomedtracker is a web-based platform that tracks and analyzes clinical and regulatory events so you can quickly and accurately assess a drug’s probability of technical success. Meddevicetracker is an interactive source of in-depth medical technology intelligence covering device markets, companies, and products.


Together, Biomedtracker and Meddevicetracker arm you with the crucial information you need to prioritize opportunities, identify unmet needs, and stay ahead of the competition.



Download now